Australia - English - Department of Health (Therapeutic Goods Administration)

macopharma australia pty ltd - 46346 - blood donor set, paediatric - intended to be used for the collection, filtration and transfer of blood and blood components

Australia - English - Department of Health (Therapeutic Goods Administration)

etac anz pty ltd - 10797 - chair, paediatric - x:panda is a multi-adjustable dynamic seat, delivered in 4 different sizes - each seat with up to 10 cm in seat width and depth adjustment coupled with sliding back growth. the back is dynamic, making it possible for the child to extend and push back against relatively light resistance and then regain the desired sitting position. the back is lockable which could be preferred in feeding situations and required when being used in transportation. the back can also be angled to make it possible to seat the child with either an open or closed hip angle.

Australia - English - Department of Health (Therapeutic Goods Administration)

etac anz pty ltd - 10797 - chair, paediatric - the panda futura seat is available in two different versions: standard and active. the standard seat is primarily for children with the need of support around arms and shoulders. the active seat is for the active children who need more freedom of movement.

Australia - English - Department of Health (Therapeutic Goods Administration)

etac anz pty ltd - 10797 - chair, paediatric - combined with the superb design, the wombat appears as an exceptional activity chair. the wombat is available in two versions: wombat basic and wombat upgrade. the difference is found in the frames. the basic frame has simple height adjustment on a center bar. the upgrade frame is constructed using highly technical production processes allowing the frame to adjust from floor to table height.

Australia - English - Department of Health (Therapeutic Goods Administration)

getinge australia pty ltd - 17643 - oxygenator, extracorporeal membrane - the quadrox-id pediatric oxygenator oxygenates the blood, removes carbon dioxide and regulates the blood temperature. the quadrox-id peadiatric oxygenator is intended for extracorporeal pulmonary support and cardiovascular support.

Australia - English - Department of Health (Therapeutic Goods Administration)

draeger australia pty ltd - 14361 - ventilator, neonatal/paediatric - for the ventilation of premature and newborn babies and for infants up to 20 kg for the ventilation modes: controlled ventilation (ippv), synchronised ventilation (sippv), intermittent mandatory ventilation (imv), synchronised intermittent mandatory ventilation (simv) and spontaneous breathing with positive airway pressure (cpap). the device also has integrated monitoring for airway pressure, inspiratory oxygen concentration and minute volume.

Australia - English - Department of Health (Therapeutic Goods Administration)

smiths medical australasia pty ltd - 14361 - ventilator, neonatal/paediatric - this device is specifically intended to be used to ventilate/resuscitate neonates and infants during transport or in a hospital environment.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - phenytoin 6 mg/ml - oral suspension - 30 mg/5ml - active: phenytoin 6 mg/ml excipient: aluminium magnesium silicate carmellose sodium carmoisine citric acid monohydrate ethanol imitation banana flavour 510120e glycerol polysorbate 40 purified water sodium benzoate sucrose sunset yellow fcf terpeneless orange oil vanillin

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - phytomenadione 10 mg/ml - solution for injection - 10 mg/ml - active: phytomenadione 10 mg/ml excipient: glycocholic acid hydrochloric acid lecithin sodium hydroxide water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - digoxin 0.05 mg/ml;   - elixir - 0.05 mg/ml - active: digoxin 0.05 mg/ml   excipient: citric acid monohydrate dibasic sodium phosphate ethanol lime flavour 70.80.0303 methyl hydroxybenzoate propylene glycol purified water quinoline yellow sucrose - lanoxin is indicated in the management of chronic cardiac failure where the dominant problem is systolic dysfunction. its therapeutic benefit is greatest in those patients with ventricular dilatation. lanoxin is specifically indicated where cardiac failure is accompanied by atrial fibrillation.